UNIGE document Scientific Article
previous document  unige:19176  next document
add to browser collection

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder

Polosan, Mircea
Jaafari, Nematollah
Baup, Nicolas
Welter, Marie-Laure
Fontaine, Denys
du Montcel, S. T.
Yelnik, J.
show hidden authors show all authors [1 - 35]
Published in The New England journal of medicine. 2008, vol. 359, no. 20, p. 2121-2134
Abstract BACKGROUND: Severe, refractory obsessive-compulsive disorder (OCD) is a disabling condition. Stimulation of the subthalamic nucleus, a procedure that is already validated for the treatment of movement disorders, has been proposed as a therapeutic option. METHODS: In this 10-month, crossover, double-blind, multicenter study assessing the efficacy and safety of stimulation of the subthalamic nucleus, we randomly assigned eight patients with highly refractory OCD to undergo active stimulation of the subthalamic nucleus followed by sham stimulation and eight to undergo sham stimulation followed by active stimulation. The primary outcome measure was the severity of OCD, as assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), at the end of two 3-month periods. General psychopathologic findings, functioning, and tolerance were assessed with the use of standardized psychiatric scales, the Global Assessment of Functioning (GAF) scale, and neuropsychological tests. RESULTS: After active stimulation of the subthalamic nucleus, the Y-BOCS score (on a scale from 0 to 40, with lower scores indicating less severe symptoms) was significantly lower than the score after sham stimulation (mean [+/-SD], 19+/-8 vs. 28+/-7; P=0.01), and the GAF score (on a scale from 1 to 90, with higher scores indicating higher levels of functioning) was significantly higher (56+/-14 vs. 43+/-8, P=0.005). The ratings of neuropsychological measures, depression, and anxiety were not modified by stimulation. There were 15 serious adverse events overall, including 1 intracerebral hemorrhage and 2 infections; there were also 23 nonserious adverse events. CONCLUSIONS: These preliminary findings suggest that stimulation of the subthalamic nucleus may reduce the symptoms of severe forms of OCD but is associated with a substantial risk of serious adverse events. (ClinicalTrials.gov number, NCT00169377.)
Keywords AdultCerebral Hemorrhage/etiologyCross-Over StudiesDouble-Blind Method*Electric Stimulation Therapy/adverse effectsFemaleHumansInfection/etiologyMaleMiddle AgedObsessive-Compulsive Disorder/*therapy*Subthalamic Nucleus
PMID: 19005196
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research group Maladie de Parkinson (911)
(ISO format)
MALLET, Luc et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. In: New England Journal of Medicine, 2008, vol. 359, n° 20, p. 2121-2134. doi: 10.1056/NEJMoa0708514 https://archive-ouverte.unige.ch/unige:19176

422 hits

1 download


Deposited on : 2012-03-27

Export document
Format :
Citation style :